Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification

Articolo

Data di Pubblicazione:

2017

Citazione:

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification / Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Ciolli, Stefania; Mauro, Francesca Romana; Mannina, Donato; Del Poeta, Giovanni; D’Arena, Giovanni; Massaia, Massimo; Coscia, Marta; Molica, Stefano; Pozzato, Gabriele; Efremov, Dimitar G.; Vannata, Barbara; Marasca, Roberto; Galieni, Pietro; Cuneo, Antonio; Orlando, Sonia; Piciocchi, Alfonso; Boncompagni, Riccardo; Vincelli, Donatella; Liberati, Anna Marina; Russo, Filomena; Foa, Robin. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 102:9(2017), pp. 352-355. [10.3324/haematol.2016.156901]

Abstract:

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. A Real life experience.

Tipologia CRIS:

Articolo su rivista

Keywords:

Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Risk Assessment; Rituximab; Hematology

Elenco autori: